SE9000624D0 - New use - Google Patents

New use

Info

Publication number
SE9000624D0
SE9000624D0 SE9000624A SE9000624A SE9000624D0 SE 9000624 D0 SE9000624 D0 SE 9000624D0 SE 9000624 A SE9000624 A SE 9000624A SE 9000624 A SE9000624 A SE 9000624A SE 9000624 D0 SE9000624 D0 SE 9000624D0
Authority
SE
Sweden
Prior art keywords
new use
treatment
invention concerns
infections
linomide
Prior art date
Application number
SE9000624A
Other languages
English (en)
Swedish (sv)
Inventor
B Nilsson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9000624A priority Critical patent/SE9000624D0/xx
Publication of SE9000624D0 publication Critical patent/SE9000624D0/xx
Priority to CA002076650A priority patent/CA2076650C/en
Priority to DE69120396T priority patent/DE69120396T2/de
Priority to ES91905238T priority patent/ES2089194T3/es
Priority to PCT/SE1991/000136 priority patent/WO1991012804A1/en
Priority to EP91905238A priority patent/EP0516725B1/en
Priority to AT91905238T priority patent/ATE139442T1/de
Priority to JP3505021A priority patent/JPH05503532A/ja
Priority to AU74466/91A priority patent/AU641002B2/en
Priority to DK91905238.1T priority patent/DK0516725T3/da
Priority to US08/462,050 priority patent/US5691350A/en
Priority to GR960402178T priority patent/GR3020798T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9000624A 1990-02-22 1990-02-22 New use SE9000624D0 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9000624A SE9000624D0 (sv) 1990-02-22 1990-02-22 New use
DK91905238.1T DK0516725T3 (da) 1990-02-22 1991-02-21 Ny anvendelse af Linomide
PCT/SE1991/000136 WO1991012804A1 (en) 1990-02-22 1991-02-21 New use
DE69120396T DE69120396T2 (de) 1990-02-22 1991-02-21 Neue verwendung von linomide (r)
ES91905238T ES2089194T3 (es) 1990-02-22 1991-02-21 Nuevo uso de linomide.
CA002076650A CA2076650C (en) 1990-02-22 1991-02-21 Roquinimex for treating hiv infections
EP91905238A EP0516725B1 (en) 1990-02-22 1991-02-21 New use of linomide (r)
AT91905238T ATE139442T1 (de) 1990-02-22 1991-02-21 Neue verwendung von linomide (r)
JP3505021A JPH05503532A (ja) 1990-02-22 1991-02-21 レトロウイルス感染治療用医薬
AU74466/91A AU641002B2 (en) 1990-02-22 1991-02-21 Method of treatment of retrovirus infections
US08/462,050 US5691350A (en) 1990-02-22 1995-06-05 Use of linomide for treatment of retrovirus infections specifically HIV infections
GR960402178T GR3020798T3 (en) 1990-02-22 1996-08-14 New use of linomide (r)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9000624A SE9000624D0 (sv) 1990-02-22 1990-02-22 New use

Publications (1)

Publication Number Publication Date
SE9000624D0 true SE9000624D0 (sv) 1990-02-22

Family

ID=20378638

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9000624A SE9000624D0 (sv) 1990-02-22 1990-02-22 New use

Country Status (11)

Country Link
EP (1) EP0516725B1 (el)
JP (1) JPH05503532A (el)
AT (1) ATE139442T1 (el)
AU (1) AU641002B2 (el)
CA (1) CA2076650C (el)
DE (1) DE69120396T2 (el)
DK (1) DK0516725T3 (el)
ES (1) ES2089194T3 (el)
GR (1) GR3020798T3 (el)
SE (1) SE9000624D0 (el)
WO (1) WO1991012804A1 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9201076L (sv) * 1992-04-06 1993-10-07 Shimon Slavin Användningen av gamla läkemedel för behandling av diabetes
IL108459A0 (en) * 1993-02-05 1994-04-12 Opjohn Company 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses
SE9400810D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of Quinoline-3-carboxamide compounds
SE9400809D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of quinoline-3-carboxamide compounds
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
CA2312406A1 (en) * 1997-12-15 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Drugs augmenting nkt cells
JP4523281B2 (ja) * 2002-01-17 2010-08-11 メルク・シャープ・エンド・ドーム・コーポレイション Ｈｉｖインテグラーゼ阻害薬として有用なヒドロキシナフチリジノンカルボキサミド類
EP2060269A3 (en) 2003-12-08 2009-08-19 Hybridon, Inc. Modulation of immunostimulatory properties by small oligonucleotide-based compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52670B1 (en) * 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation

Also Published As

Publication number Publication date
ATE139442T1 (de) 1996-07-15
DE69120396D1 (de) 1996-07-25
EP0516725A1 (en) 1992-12-09
AU7446691A (en) 1991-09-18
CA2076650A1 (en) 1991-08-23
DE69120396T2 (de) 1997-01-30
WO1991012804A1 (en) 1991-09-05
AU641002B2 (en) 1993-09-09
DK0516725T3 (da) 1996-09-09
GR3020798T3 (en) 1996-11-30
ES2089194T3 (es) 1996-10-01
EP0516725B1 (en) 1996-06-19
JPH05503532A (ja) 1993-06-10
CA2076650C (en) 1998-04-28

Similar Documents

Publication Publication Date Title
ES2134764T3 (es) Inhibidores de hiv proteasa.
SE8704298D0 (sv) Compounds for use in therapy
TW224942B (el)
ES2093650T3 (es) Una solucion farmaceutica que comprende derivados de fk506.
ZA913910B (en) Use of baclofen for obtaining medicaments for the treatment of angina pectoris
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
ES2089136T3 (es) Tratamiento de enfermedades inflamatorias con la ayuda de derivados 15-ceto-prostaglandinas.
DK132188A (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
SE9000624D0 (sv) New use
DK0424156T3 (da) Behandling af hepatobiliær sygdom med 15-ketoprostaglandinforbindelser
FI952420A0 (fi) Glukopyranosidibentsotiofeenit
FI911138A (fi) Ny substituerad aminfoerening och foerfarande foer dess framstaellning.
MX13723A (es) Procedimiento para preparar derivados de 9-desoxo-9a-alil- y propargil-9a-aza-9a-homoeritromicina a
ES2113345T3 (es) Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina.
DK0454429T3 (da) Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme
ATE146964T1 (de) Behandlung von katarakt mit prostacyclinverbindungen
ES2114891T3 (es) Nuevas formulaciones farmaceuticas de 5-(2-cloro-1-hidroxietil)-4-metiltiazol.
SE9000288D0 (sv) New use
MX9202948A (es) Uso de atipamezol.
NO903585D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksaziner.
IT1233376B (it) Composizione farmaceutica contenente n-acetil-cisteina e suo impiego
IT1245631B (it) Impiego di composti macrolidi come agenti anti-infiammatori per il trattamento di malattie provocate da cessione di istamina